ArticleInternational urology and nephrology2026
Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Comment on "Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study".International urology and nephrology · 2026Article
- Development and validation of a machine learning-based prediction model for malnutrition risk in peritoneal dialysis patients: a multi‑center retrospective study.International urology and nephrology · 2026Article
- Ferroptosis and interstitial cystitis: a systematic review of preclinical evidence and molecular mechanisms.International urology and nephrology · 2026Review
- Perillaldehyde inhibits oxidative stress, NLRP3-mediated inflammation and fibrosis in diabetic nephropathy through regulating HMOX1.Hereditas · 2026Article
- Mitochondrial dysfunction as the missing mechanistic link between hand grip strength and CKD progression.International urology and nephrology · 2026Article
- The role of ALOX15 in inflammation-related diseases.Frontiers in immunology · 2026Review
- Ferroptosis regulation by SGLT2 inhibitors: mechanisms and clinical benefits in diabetic kidney disease.Frontiers in pharmacology · 2026Review
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
purposeTo delineate the renal expression of ferroptosis-driving proteins ALOX15 and HMOX1 in DN and to determine their relationship with intra-renal inflammatory activity.
methodsIn this prospective, single-centre cross-sectional study, 150 consecutive biopsy-proven DN patients and 150 age- and sex-matched type 2 diabetes mellitus (T2DM) controls without nephropathy were enrolled between April 2021 and April 2025. After identifying the intersection of ferroptosis- and DN-related transcriptomic signatures by integrative bioinformatics, Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrichment was performed. Demographics, routine biochemistry and concurrent inflammatory indices were captured. Serum concentrations of ALOX15, HMOX1, IL-1β, IL-6 and TNF-α were quantified in duplicate by validated high-sensitivity ELISA.
resultsCompared with T2DM controls, DN patients exhibited a longer diabetes duration, higher fasting plasma glucose (FBG), glycated haemoglobin (HbA1c), serum creatinine (Scr), blood urea nitrogen (BUN) and urine albumin-to-creatinine ratio (UACR), and a markedly lower estimated glomerular filtration rate (eGFR) (all P < 0.05). Circulating ALOX15 and HMOX1 were significantly elevated in DN (both P < 0.05). Multivariable logistic regression identified increased Scr, UACR, ALOX15 and HMOX1, together with reduced eGFR, as independent risk factors for DN (all P < 0.05). ROC analysis revealed AUCs of 0.750, 0.726 and 0.881 for ALOX15 alone, HMOX1 alone and their combination, respectively, in predicting DN. Both ferroptosis markers correlated positively with IL-1β, IL-6 and TNF-α (all P < 0.001).
conclusionALOX15 and HMOX1 are markedly up-regulated in DN and tightly linked to systemic inflammation. Their combined quantification offers robust diagnostic performance and positions these ferroptosis executors as candidate therapeutic targets for early interception of DN.
Indexed as
Identifiers
41379387What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.